期刊文献+

HPV 病毒 E2mRNA 检测在宫颈病变筛查中的临床价值 被引量:2

Clinical significance of HPV -E2 mRNA detection in screening of cervical lesions
原文传递
导出
摘要 目的:探讨 HPV 病毒 E2mRNA 检测在宫颈病变筛查中的临床价值。方法收集582例 HR-HPV 阳性,TCT≤LSIL 的宫颈脱落细胞标本,应用 RT-PCR 检测 HPV 病毒 E2mRNA 的不同级别的宫颈病变表达并进行比较,评价其用于筛查宫颈病变的灵敏度、特异度、阳性预测值与阴性预测值等。结果随着宫颈病变恶性程度的升高,HPV 病毒 E2 mRNA 的表达呈下降趋势(χ2=132.72,P <0.01)。细胞学结果正常/炎症组中,E2mRNA 筛查宫颈病变的灵敏度为77.2%、特异度为96.8%、阳性预测值为75.6%、阴性预测值为96.0%;ASCUS 组以上各值为:81.0%、91.7%、79.1%、92.6%;LSIL 组以上各值为:95.9%、93.4%、94.7%、95.0%。结论HPV 病毒 E2基因断裂、表达缺失在宫颈细胞癌变的早期起重要作用。在临床进行 HPV 病毒E2mRNA 检测对宫颈病变的早起筛查和预后评估有一定的价值。 Objective To investigate the expression of human papillomavirus E2 mRNA in cervical cytologi-cal specimens as well as the role of that in cervical carcinogenesis and its clinical significance in screening and evalat-ing prognosis of cervical lesions.Methods The expression of E2 mRNA in 582 cases of cervical cytological speci-mens with high risk human papillomavirus infection and cytological diagnosis of NILM,ASCUS and LSIL,was detected by RT -PCR.Thereafter,all cases were divided into the four groups by colposcopy and histopathological confirmation, including 414 cases of cervicitis,95 cases of CINⅠ,51 cases of CINⅡ,20 cases of CINⅢ and 2 cases of invasive cervical carcinoma as well.Results The expression of HPV -E2 mRNA decreased dramatically corresponding with pathological upgrading from groups of cervicitis to invasive cervical carcinoma (χ2 =132.72,P 〈0.05).The sensitiv-ity,specificity,positive predictive value and negative predictive value of HPV -E2 mRNA for screening potential cervical lesions in group of NILM,ASCUS and LSIL were 77.2%,96.8%,75.6%,96.0% and 81.0%,91.7%, 79.1%,92.6% as well as 95.9%,93.4%,94.7%,95.0% respectively.Conclusion Deletion of HPV -E2 induced by genetic disruption played an important role in the early stage of malignant transformation of cervical epithe-lial cells.Therefore,detection of the levels of HPV -E2 mRNA expression might be clinically valuable for the screen-ing and evaluating of prognosis in cervical lesions.
出处 《中国基层医药》 CAS 2015年第10期1468-1471,共4页 Chinese Journal of Primary Medicine and Pharmacy
基金 广东省深圳市科技计划项目(医疗卫生类)(201003104)
关键词 宫颈上皮内瘤变 宫颈肿瘤 mRNA HPV -E2 E2mRNA Cervical intraepithelial neoplasia Cervical neoplasms
  • 相关文献

参考文献11

  • 1Sasagawa T, Takagi H, Makinoda S. Immune responses against hu-man papillomavirus (HPV) infection and evasion of host defense in cervical cancer[J]. J Infect Chemother ,2012,8(6) 807-815.
  • 2Lagunas-Martfnez A, Madrid-Marina V. Modulation of apoptosis by early human papillomavirus proteins in cervical caneer [J]. Bioehim Biophys Aeta,2010,1805(1):6-16.
  • 3Zheng G, Schweiger MR, Martinez-Noel G, et al. Brd4 Regulation of Papillomavirus Protein E2 Stability [J]. J Virol, 2009, 83 (17):8683-8692.
  • 4Gaguon D, Joubert S, Senrehal H, et al. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-eontaining protein 4 [J 1. J Virol, 2009,83 (9):4127-4139.
  • 5Apgar AB, Zosehnick I, Wright TC. The 2001 Bethesda System terminology[J]. Am Faro Physician,2003,68 (1):1992-1998.
  • 6Schwarz E, Freese UK, Gissmann L, et al. Structure and transcrip-tion of human papillomavirus sequences in cervical carcinoma cells [J]. Nature, 1985,314 (6006):111-114.
  • 7Vinokurova S, Wentzensen N, Kraus I, et al. Type-dependent inte-gration frequency of human papillomavirus genomes in cervical le-sions[J]. Cancer Res,2008,68 (1):307-313.
  • 8Criecca M, Venturoli S, Leo E, et al. Disruption of HPV 16 Eland E2 genes in preconcerous cervical lesions [J]. J Virol Methods, 2009,158(12):180-183.
  • 9Hmnid N A, Brown C, Gaston K, et al. The regulation of eell pro-liferation by the papillomavirus early proteins[J]. J Cell Mol Life Sei,2009,66(10):1700-1717.
  • 10黄卓敏,江曼茹,王楚莹,姚吉龙,谢建生.Brd4与HPV-16病毒E2在宫颈脱落细胞中的表达及意义[J].实用医学杂志,2012,28(19):3198-3201. 被引量:7

二级参考文献10

  • 1Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer [J]. Clin Sci (Lond), 2006, 110(5): 525-541.
  • 2Liu S S, Tsang P C, Chan K Y, et al. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas [J]. Turnout Biol, 2008, 29 (2) : 105-113.
  • 3Tay S K, Ngan H Y, Chu T Y, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hang Kong, Singapore and Taiwan [J]. Vaccine, 2008, 26(12):60-70.
  • 4Lagunas-Martinez A, Madrid-Marina V. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer [J]. Biochim Biophys Aeta,2010, 1805 ( 1 ) : 6-16.
  • 5Zheng G, Schweiger M R, Martinez-Noel G, et al. Brd4 regulation of papillomavirus protein E2 stability [J]. J Virol, 2009, 83(17) : 8683-8692.
  • 6Gagnon D, Joubert S, Senechal H, et al. Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4 [J]. J Virol, 2009, 83(9):4127-4139.
  • 7Apgar B S, Zoschnick L, Wright T C Jr. The 2001 Bethesda System terminology [J]. Am Fam Physician, 2003, 68 (10): 1992-1998.
  • 8Manavi M, Hudelist G, Fink-Retter A, et al. Human papillomavirus DNA integration and messenger RNA transcription in cervical low-and high-risk squamous intraepithelial lesions in Austrian women [J]. Int J GynecolCancer, 2008, 18(2):285-294.
  • 9Criecca M, Venturoli S, Leo E, et al. Disruption of HPV 16 E1 and E2 genes in preconcerous cervical lesions [J]. J Virol Methods, 2009, 158(12) : 180-183.
  • 10Hmnid N A, Brown C, Gaston K, et al. The regulation of cell proliferation by the papillomavirus early proteins [J]. J Cell Mol Life Sci, 2009, 66(10) : 1700-1717.

共引文献6

同被引文献23

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部